≡

Multiplex Assay Kit for Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2) ,etc. by FLIA (Flow Luminescence Immunoassay)

C14orf141; LTBP3

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 81-101 87
EDTA plasma(n=5) 78-91 83
heparin plasma(n=5) 82-92 85

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 82-91% 98-105% 92-99% 87-101%
EDTA plasma(n=5) 87-105% 87-103% 78-89% 96-103%
heparin plasma(n=5) 97-105% 85-96% 87-94% 96-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:LTBP2) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
International Journal of Cancer Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma Pubmed:24803312
Int J Cancer Osteopontin and latent‐TGF β binding‐protein 2 as potential diagnostic markers for HBV‐related hepatocellular carcinoma PubMed: 24803312
Biology of Blood and Marrow Transplantation Association of Plasma CD163 Concentration with De Novo–Onset Chronic Graft-versus-Host Disease pubmed:28455006
Biology of Blood and Marrow Transplantation Association of plasma CD163 concentration with de novo-onset chronic graft-versus-host disease 10.1016:j.bbmt.2017.04.019
Clinical Science LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis Pubmed:30006483
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB630Hu01 Recombinant Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2) Positive Control; Immunogen; SDS-PAGE; WB.
PAB630Hu01 Polyclonal Antibody to Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2) WB; IHC; ICC; IP.
MAB630Hu22 Monoclonal Antibody to Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2) WB; IHC; ICC; IP.
SEB630Hu ELISA Kit for Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB630Hu Multiplex Assay Kit for Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSB630Hu01 ELISA Kit DIY Materials for Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP2) Main materials for "Do It(ELISA Kit) Yourself"